Primer: Sichuan Biokin Pharmaceutical Co Ltd (SBP12 HK) - Aug 2026
Sichuan Biokin Pharmaceutical is a commercial-stage biopharmaceutical company at the forefront of China's rapidly growing oncology market, with...
102 Views
Sichuan Biokin Pharmaceutical Co Ltd (SBP12 HK): Synthetic Expert Call Transcript (09 Aug 2026)
First-in-Class Validation & Commercial Ramp: Iza-bren (BL-B01D1) secured its first NMPA approval on June 22, 2026, for recurrent or...
103 Views
IPO Databook: Sichuan Biokin Pharmaceutical (HK) - Aug 2026
Sichuan Biokin Pharmaceutical Co., Ltd. is an integrated biopharmaceutical group founded in 1996, focused on developing oncology therapeutics...
120 Views
Index Rebalance & ETF Flow Recap: FRTIB, Japan, CSI300, CSI500, STAR50, WuXi XDC, Asahi
This recap highlights Insights covering Asian index rebalances (announcements/ forecasts/ IPO Fast Entry/ M&A driven changes). We also highlight...
1.1k Views
MS-China March 2026 Rebalance: Post-Event Review
A retrospective look at the MSCI China Feb 2026 rebalance: cross-window alpha, FF/ADV bucket cuts for ADD and DELETE, and the implementation-day...
301 Views